Elite Pharmaceuticals (ELTP) EBITDA (2010 - 2026)
Elite Pharmaceuticals (ELTP) posted EBITDA of $7.78 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 64.6% from $21.98 million a year earlier and down 25.4% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) EBITDA (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Elite Pharmaceuticals was $35.99 million, down 6.6% year-over-year; for FY2026 (ended Mar 31, 2026), it was $50.18 million, up 141.0% from FY2025.
- Annual EBITDA has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 71.1% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' EBITDA was $20.83 million in FY2025 (+72.0%), $12.11 million in FY2024 (+144.5%), $4.95 million in FY2023 (-21.1%) and $6.28 million in FY2022 (+83.7%).
- The fiscal Q1 2027 figure stands as the lowest quarterly EBITDA since fiscal Q3 2025.
- On a year-over-year basis, EBITDA increased in five of the last eight quarters, with growth averaging 152.7%.
- The strongest year-over-year quarter for EBITDA in the past five years was fiscal Q3 2026, with growth of 557.9%; the weakest was fiscal Q1 2027, with a decline of 64.6%.
- According to Business Quant data, EBITDA for the three prior fiscal quarters was $10.44 million (Q4 2026), $9.28 million (Q3 2026) and $8.49 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Elite Pharmaceuticals | 258.43 Mn | 140.10 Mn | 13.51 Mn | 7.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.90 Mn |
| Mar 31, 2026 | 10.56 Mn |
| Dec 31, 2025 | 9.40 Mn |
| Sep 30, 2025 | 8.61 Mn |
| Jun 30, 2025 | 22.09 Mn |
| Mar 31, 2025 | 11.56 Mn |
| Dec 31, 2024 | 1.53 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 3.87 Mn |
| Sep 30, 2023 | 2.25 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | -42,808.00 |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 2.13 Mn |
| Sep 30, 2021 | 1.72 Mn |
API Access
Elite Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();